W.L. Gore gets expanded FDA approval for endovascular graft

01/17/2012 | HealthDay News

The FDA has granted approval to W.L. Gore and Associates to expand the use of its Gore Tag Thoracic Endoprosthesis device, an endovascular graft initially approved for aneurysm treatment. The expanded label allows the use of the device for treating patients with aortic tears.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX